论文部分内容阅读
目的:分析研究米非司酮治疗功能性子宫出血的临床应用价值。方法:选择我院从2013年2月到2013年10月收治的功能性子宫出血患者83例,按照用药方法不同分为两组,甲组43例给予安宫黄体酮口服,乙组40例采用米非司酮口服治疗,对比分析两组患者的治疗效果、不良反应发生情况以及疾病复发情况。结果:乙组患者的治疗有效率、不良反应、复发率明显优于甲组,差异存在统计学意义(P<0.05)。结论:给予功能性子宫出血患者采用米非司酮治疗,临床治疗效果显著,安全可靠,预后效果良好。
Objective: To analyze the clinical value of mifepristone in treating functional uterine bleeding. Methods: Eighty-three patients with functional uterine bleeding who were treated in our hospital from February 2013 to October 2013 were divided into two groups according to the method of administration. Group A was given progestogen progesterone acetate in group A Mifepristone oral treatment, comparative analysis of two groups of patients with treatment, adverse reactions and disease recurrence. Results: The effective rate, adverse reactions and recurrence rate of patients in group B were significantly better than those in group A, the difference was statistically significant (P <0.05). Conclusion: Mifepristone treatment in patients with functional uterine bleeding is significant, safe and reliable, and the prognosis is good.